Arcus Biosciences, Inc.
RCUS· NYSE
Released May 2, 2019, before the open
10-Q filed May 2, 2019, 32 days after period end · 0001564590-19-015333
| Metric | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|
| Revenue | $1.75M | $1.25M | — |
| Net Income | -$17.67M | -$12.95M | -$7.20M |
| EPS Diluted | -$0.41 | -$1.37 | -$4.96 |
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.